3. Clinical outcome.
| Study ID | Type of material (surgical technique) | Proportion of successful procedures at 1‐5 years after surgery (no exposure/extrusion) | Adverse outcomes (i.e.infection or migration) | Horizontal implant motility (mm) | Vertical implant motility (mm) | |
| Integrated | Non‐integrated | RR (95% CI) | RR (95% CI) | MD (95% CI) | MD (95% CI) | |
| Colen 2000 | HA (enucleation) | Acrylic (enucleation) | — | — | — | — |
| Shome 2010 | PP (enucleation) | PMMA traditional (enucleation) | 0.92 ( 0.84 to 1.01) N = 150 |
17.82 (0.98 to 324.67) N = 150 |
1.96 (1.01 to 2.91) N = 100 |
(3.12 (2.36 to 3.88) N = 100 |
| PP (enucleation) |
PMMA myoconjunctival (enucleation) |
−0.57 ( −1.63 to 0.49) N = 100 |
(−0.20 (−1.28 to 0.88) N = 100 |
|||
| Tari 2009 | HA (enucleation) |
Alloplastic (evisceration) |
1.02 (0.95 to 1.09) N = 100 |
— | −3.35 ( −4.08 to −2.62) N = 100 | (−2.76 (−3.45 to −2.07) N = 100 |
HA: hydroxyapatite; MD: mean difference; PMMA: polymethylmethacrylate; PP: porous polyethylene; RR: risk ratio.